Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific | 2021

Growing AF treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific EP mapping and ablation device market through 2029. However, the COVID-19 global pandemic will have an impact on the Asia Pacific EP mapping and ablation device market, resulting in lost procedure volumes in the short term followed by a period of recovery. This is expected to reduce the growth of the EP mapping and ablation device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Urological Devices – Market Insights – Asia Pacific
Driven by rising kidney stone prevalence and an aging population, the Asia Pacific urological device market will grow at a modest rate through 2034. Other contributing factors for growth include an…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2034, driven by the rapid expansion of AF ablation procedures and the coinciding uptake of PFA devices, which…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…